C07C 211/28
Having amino groups linked to the six-membered aromatic ring by unsaturated carbon
Official title: having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
C07C211/28 (Having amino groups linked to the six-membered aromatic ring by unsaturated carbon) appears on 61 US grants and 54 published applications in this corpus.
Search patents in C07C- Granted patents
- 61
- Published applications
- 54
- Assignees
- 51
- Inventors
- 215
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 8 | 0 |
| 2001 | 5 | 1 |
| 2002 | 1 | 3 |
| 2003 | 3 | 1 |
| 2004 | 1 | 5 |
| 2005 | 1 | 0 |
| 2006 | 2 | 2 |
| 2007 | 1 | 2 |
| 2008 | 2 | 1 |
| 2009 | 0 | 4 |
| 2010 | 0 | 1 |
| 2011 | 2 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 3 |
| 2014 | 3 | 3 |
| 2015 | 1 | 6 |
| 2016 | 3 | 4 |
| 2017 | 2 | 3 |
| 2018 | 4 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors26 May 2026US 12,636,266 B2Rivo Bio, Inc.
- Substituted piperazines as disrupters of AB42 oligomer formation27 May 2025US 12,312,296 B2Acelot, Inc.
- Substituted amines as disrupters of ABETA42 oligomer formation28 Nov 2023US 11,827,582 B2Acelot, Inc.
- Vinylogous phenethylamines as neurotransmitter releasers26 Jan 2021US 10,899,699 B2Research Triangle Institute
- Small molecule drugs and related methods for treatment of diseases related to Aβ42 oligomer formation7 Jul 2020US 10,703,711 B2Acelot, Inc.
- Small molecule drugs and related methods for treatment of diseases related to ab42 oligomer formation25 Jun 2026US 2026/0176230 A1Acelot, Inc.
- Two-dimensional covalent organic frameworks for harvesting mechanical energy12 Feb 2026US 2026/0042725 A1City University of Hong Kong
- Amine containing polymers and lubricant compositions including such polymers and methods of using thereof7 Aug 2025US 2025/0250380 A1
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors17 Jul 2025US 2025/0228798 A1Rivo Bio, Inc.
- Novel compound for degradation of target protein or polypeptide by polyubiquitination26 Dec 2024US 2024/0425517 A1Prazer Therapeutics Inc.
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Calcium receptor-active compounds114US 6,211,244 B1NPS Pharmaceuticals, Inc. · 2001
- Non-steroidal ligands for the estrogen receptor64US 5,681,835 AGlaxo Wellcome Inc. · 1997
- Sigma receptor ligands and the use thereof56US 6,087,346 ACambridge NeuroScience, Inc. · 2000
- Non-steroidal ligands for the estrogen receptor46US 5,877,219 AGlaxo WellcomeInc. · 1999